EnhancerAtlas 2.0: an updated resource with typical enhancer annotation in 600 tissue/cell types across nine species
EnhancerAtlas 2.0
TagContent
EnhancerAtlas ID
HS165-09255 
Organism
Homo sapiens 
Tissue/cell
Ramos 
Coordinate
chr21:45615200-45617050 
SNPs
Number: 3             
IDChromosomePositionGenome Version
rs762421chr2145615561hg19
rs7282490chr2145615741hg19
rs4456788chr2145616324hg19
TF binding sites/motifs
Number: 2             
TFJASPAR IDCoordinateMotif SequenceStrand-Log10(p-value)
SPI1MA0080.4chr21:45616347-45616361TGCTTCCTCTTTTC-6
SPICMA0687.1chr21:45616347-45616361TGCTTCCTCTTTTC-6.1
Number of super-enhancer constituents: 28             
IDCoordinateTissue/cell
SE_00694chr21:45616149-45617521Adipose_Nuclei
SE_03880chr21:45610262-45615425Brain_Anterior_Caudate
SE_03880chr21:45616016-45617515Brain_Anterior_Caudate
SE_04775chr21:45609944-45617953Brain_Cingulate_Gyrus
SE_05779chr21:45610164-45618120Brain_Hippocampus_Middle
SE_06690chr21:45610194-45617897Brain_Hippocampus_Middle_150
SE_07737chr21:45615485-45617603Brain_Inferior_Temporal_Lobe
SE_10305chr21:45615103-45617503CD19_Primary
SE_11616chr21:45614519-45618143CD20
SE_24239chr21:45615918-45616296Colon_Crypt_2
SE_24239chr21:45616358-45616947Colon_Crypt_2
SE_30176chr21:45612703-45617986Fetal_Muscle
SE_31647chr21:45615831-45617002Gastric
SE_33667chr21:45611717-45615585H2171
SE_40890chr21:45610212-45615559Left_Ventricle
SE_40890chr21:45615577-45618069Left_Ventricle
SE_42286chr21:45615697-45617796Lung
SE_48538chr21:45614456-45617946Psoas_Muscle
SE_50113chr21:45612958-45615570Sigmoid_Colon
SE_50113chr21:45615772-45617519Sigmoid_Colon
SE_51445chr21:45609930-45618288Skeletal_Muscle
SE_52463chr21:45612982-45615536Small_Intestine
SE_52463chr21:45615642-45617687Small_Intestine
SE_59125chr21:45557380-45640832Ly3
SE_61237chr21:45557180-45641526HBL1
SE_61527chr21:45545883-45641600Toledo
SE_62281chr21:45556124-45641130Tonsil
SE_65639chr21:45615968-45617001Pancreatic_islets
Diseases: AD,Huntington,Obesity,Parkinson,Prostate cancer,Schizophrenia and Sleep disorder
Number of disease enhancers: 1             
ChromosomeStartEnd
chr214561565445615733
Number: 2             
IDChromosomeStartEnd
GH21I005064chr214561583045617229
GH21I044192chr214561202445617843
Enhancer Sequence
GCCAGAGACC CCCTCTGAGA AATGGGATGG CTCCAGCTGG GAAGCCCCCG CCCTGCCAAG 60
GAATGTCACG AGCCTCAAGC AGATTTGCTC TTAGATATTT CTTTTTAATC GAGTCTAACA 120
GTGATTGTTG AGCCGTCCTT CATTTTTTTT TTTTTTTGTA AGATGCCTCT GTCAAGAAGG 180
AGCCACGAGT TGGCTTTCAT GGAATGGGTG CTCTTGGTGG CCAAATAGAA ATAAAACCTG 240
GCTGTCTGGT CCTGATCCAC TCACAGAAGT GGCGTAAACA CCTTATTTAT GATCTGGGAC 300
ATTCAACACC ATCTTATAAA AGATTCATAG AATACACATT CACACACCCA CAAAAATCAA 360
GAGAGCAGAT TTTCCAAAAA TAGGTGCAAG AAAGATCCAA CTTCCAGGAT AAAATTTTAG 420
AACCAACATT TCCATTAGCA AAAGCGGTCT TGTCTAAAAC TCTACCGACC GCGCTAAAAT 480
CCCATTCAAA ACAGAGCTCT GGTTACGTAG ATCGTGATCA ATAATGAGAA ACTGTGAGGC 540
GTCCCCGTGG GATCTGACAC TTCCTAGGGG AGCTTCTCTC CACTGGTAAT AAAGATATAA 600
TTAGGAATTT CAACTACCTG TGATTTTGCC AACTTACGGC ATTTGTTGAG AATTTCGGTC 660
CCTGTGTTTA TGCACACACC TTTCAACCTT AGATTTGACG GTGATGGGTT AGTAAATGTC 720
AATTCTAAAG TGGTCGTTTT CAACCAGGGG CAATTTTACC CCTCAGGGGA CACTGGCAGT 780
GTCTGGAGAC ATGTTTGGTT GTCATGACTT GGGGCAGAGG TGCCACGGGC ACCTGGAGGG 840
TGGAGGCCGG GGTGCGGCTC AATACCCTAA CCACACAGGA TGGCCCCAGG ACAAAGATGC 900
CCCTGGTGCT GAGAGCAGGG CCCTGTTCTA AGAGATGGGT GGCTGGAGCC TGGCTGGAGG 960
GCACTAGTGG CACTCTGGGC TGGTCTCCCA GGGCCCCATC TGCCAGGTCG GGGGCCCACG 1020
TGGGCCTGCA GGATGTGCGT GCTTCTCTGC TGTTGAGATT GCATCAGCAC AACAGCCACA 1080
GCCGTGACAC GGGGGCAGGC ACCTCAGTGA CGCCAGAGTC GGGGCGGGAG GTGTGGAGAT 1140
CTGGGCTTGC TTCCTCTTTT CAGTCCCAGG ACAGCTCCTC TTTGGCTGTG GGAGGCCCAG 1200
CTTCAGCCTT GTCTGTGGCT TCCTGGTGGG AGGACACAGG CCTTGAGGGA CGTTTGTCCG 1260
AGACGGTCCT CATCCTACTG GTAGGGACAC AGAGCACCTG TTCCTCTGGC CCCTCCAGGA 1320
GCAAGACACA TGCACTGCTG AGGCCTTGGA AGCCTACACA GGTTTATCAC CCACGGCCAG 1380
ACCTGTCTGT CAGGGAGCAG GTGGGGTCAT CCTGCCCTGA AGCACCGATG AGCTGATCCC 1440
GGTCATGCAG AGTGGGTGGG GACCTCTTGG CTGGGCCTGT TCATGTAGCA CACACGGCTT 1500
TGCTGCCCAT AGAATCCAGG GCCCCCAGTG TGAGCACCAC TCTCCATCCC TGAGGCCGAG 1560
CCTTACCCTG GAGGCAGCCT CAGGTGAGAT GCCCCTAATG GAGCCACCTG GCAATGGACC 1620
GCTCTCAGGT CCTTCAGCTC GGTGCACTCA CCCGGGAGCC CTGCGTTCTG TCCTGGGGTA 1680
GAGGCTCAGG GTTGGTTTGA AGCCATATAG TCAGCTCCCA GAGTCACAGA AACGTCCAAG 1740
GAAGAAAACT GTCCGATTAC AGACTTTTAA AATTCATTCA TAGTTTAATC AAGAGAACTT 1800
GCTGTTCCTT CCTCAAATTT CCTAGAATTG GTCTTCTCAT AATCACCACC 1850